Seiten : 1 | 2 >> (2 Seiten)
Nanostart AG's US portfolio company to be listed on the stock market
From 2 December 2005, the shares of NaturalNano Inc., a portfolio company of Nanostart AG, will be listed for trade under the ticker symbol OTCBB: NNAN at the OTC Bulletin Board

First of Nanostart AG's portfolio companies listed on the stock exchange
From 14 November, the shares of NanoFocus AG, one of Nanostart AG's portfolio companies, are admitted to the Open Market (Entry Standard) of Frankfurt Stock Exchange

Nanostart AG transfers to Entry Standard
This new sub-segment's aim is to make it easier for companies to gain market access and at the same time newly regulate the transparency demands on companies

NanoFocus AG plans to make a listing in the Entry Standard
This move would make the Oberhausen-based NanoFocus AG the first nanotechnology toolmaker to go public in Germany

Nanostart shareholding MagForce Nanotechnologies changes legal form to AG
The company gave notice today that the transformation was finalized on 6 October with the entry into the Commercial Register

Nanostart AG decides on capital increase with famous institutional investors
Nanostart AG has been able to gain a number of famous US institutional investors and one of Germany’s three biggest banks as new shareholders

Portfolio company of Nanostart AG intends to go public
The portfolio company has assigned an investment bank to launch the shares for trading at the Frankfurt Stock Exchange

Nanostart invests in NaturalNano, Inc.
The company is specialized in discovering, refining and commercializing naturally occurring nanoscale materials

Nanostart goes public
As of today, the shares of Nanostart AG, one of the leading investment companies in the emerging nanotechnology sector, will be traded on the Frankfurter Wertpapierbörse (FWB - Frankfurt Stock Exchange)

Nanostart AG invests in Lumiphore, Inc.
The company develops and produces fluorescent nano-detectors which can be used, for example, in pharmaceutical and biotechnological research and development, as well as in drug discovery and diagnostics

Seiten : 1 | 2 >> (2 Seiten)
Fontsize A A A DruckenPrint page